2023年5月16-19日，全球顶级心血管介入会议——2023年欧洲心血管介入医学大会（EuroPCR 2023）即将在法国巴黎以线上+线下会议形式揭开面纱。近日，大会官网更新了初步科学计划，包括最新揭晓的临床数据（Late-Breaking clinical data，LBCD）和临床热线研究（Clinical Hotline）；摘要、临床病例和电子海报；PCR达人秀等不容错过的精彩课程，将你感兴趣的日程加入书签，一起进行这为期4天的学习和交流吧！
LBCD：聚焦左主干和分叉病变
Tuesday 16 May 2023
EBC TWO five-year follow-up – Provisional vs. culotte for coronary bifurcations
EBC TWO试验5年随访：冠脉分叉病变的Provisional策略 vs. culotte策略
S. ArunothayarajProvisional stenting in bifurcation lesion: benefit of side branch intervention?
分叉病变的Provisional stenting术式：分支介入的益处
B. Chevalier iFR vs. FFR-guided revascularisation decision-making in left main disease
iFR vs. FFR指导下的左主干病变血运重建决策
T. Warisawa
Impact of residual ischaemia after left main bifurcation stenting on cardiovascular mortality
左主干分叉病变支架置入术后残余缺血对心血管死亡率的影响
B. XuThe European Bifurcation Club left main coronary stent study: three-year follow-up
欧洲分叉俱乐部左主干冠状动脉支架研究：3年随访
D. Hildick-Smith Dynamic coronary roadmap for contrast reduction trial
对比度降低的冠状动脉动态路径图试验
J. Escaned
LBCD：TAVI
Tuesday 16 May 2023
Outcomes of repeat TAVR with balloon-expandable valves
球囊扩张式瓣膜重复TAVR的结果
Raj Makkar Five-year outcomes with the Acurate neo2 valve: the Neo AS CE-mark study
Acurate neo2瓣膜的5年疗效：Neo AS CE-mark研究
H. Möllmann TAVR in patients with cardiogenic shock: TVT-registry analysis
心源性休克患者的TAVR：TVT注册分析
A. Dhoble Five-year outcomes for TAVI with an intra-annular, self-expandable bioprosthesis
环腔内自膨式生物瓣膜TAVI的5年疗效
L. Sondergaard Chimney stenting vs. BASILICA to prevent TAVR-related coronary obstruction
烟囱支架置入术 vs. BASILICA技术预防TAVR相关冠状动脉阻塞
A. Mangieri INTERCEPTavi: carbon-dioxide flushing reduces vascular brain injury in TAVI
INTERCEPTavi：二氧化碳冲洗减少TAVI中的血管性脑损伤
S.A. Khawaja PORTICO IDE trial: five-year outcomes of Portico vs. commercially available valves
PORTICO IDE试验：PORTICO瓣膜 vs. 商用瓣膜的5年结果
R. Makkar
LBCD：二尖瓣和三尖瓣疾病
Wednesday 17 May 2023
Early experience with a d-shape, monoleaflet TMVR system
早期使用d形单瓣TMVR系统的经验
C. Alfredo Outcomes of MViV, MViR and ViMAC: prospective MITRAL trial final results
MViV、MViR和ViMAC的结果：MITRAL前瞻性试验的最终结果
M. Guerrero DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral regurgitation
DRAGONFLY-DMR研究：经导管DragonFly装置修复二尖瓣返流
S. Lim Outcomes of TMVR vs. medical therapy for secondary mitral regurgitation
TMVR与药物治疗继发性二尖瓣返流的疗效比较
S. Ludwig HighLife transseptal mitral valve replacement: first-in-man primary end-point outcomes
HighLife经房间隔入路二尖瓣置换技术：首次人体试验主要终点结果
S. Worthley Real-world outcomes for TEER: 30-day results from the TriClip bRIGHT study
TEER的真实世界结果：TriClip bRIGHT研究的30天结果
Philipp Lurz TRILUMINATE Pivotal: randomised trial of TEER for tricuspid regurgitation
RILUMINATE Pivotal：TEER治疗三尖瓣反流的随机试验
P. Sorajja
LBCD：聚焦支架技术
Wednesday 17 May 2023
12-month primary endpoint outcomes of the BIOADAPTOR-RCT
BIOADAPTOR-RCT研究的12个月主要终点结果
Shigeru Saito Final five-year results from the blinded ABSORB IV trial
ABSORB IV盲法试验的最终5年结果
Gregg Stone BIOMAG-I: one-year clinical outcome of the resorbable magnesium scaffold-DREAMS 3G
BIOMAG-I研究：可吸收镁合金支架DREAMS 3G的1年临床结果
Michael Haude Long-term outcome after resorbable magnesium scaffold implantation
可吸收镁合金支架植入术后的长期疗效
Graziella Pompei Biodegradable polymer vs. polymer-free ultrathin sirolimus-eluting stents
可生物降解聚合物 vs. 无聚合物超薄西罗莫司药物洗脱支架的比较
Hyo-Soo Kim Clinical outcomes at three years from first-in-man LEADERS FREE III trial
首次人体LEADERS FREE III试验后三年的临床结果
Franz Eberli Randomised trial of biolimus DEB for in-stent restenosis: the REFORM study
biolimus DEB治疗支架内再狭窄的随机试验：REFORM研究
Robert Byrne Sirolimus-coated balloon vs. paclitaxel-coated balloon in de novo small vessel disease
西罗莫司涂层球囊 vs. 紫杉醇涂层球囊治疗De Novo小血管病变
Patrick Serruys
LBCD：TAVI、高血压、卒中预防
Wednesday 17 May 2023
Primary outcome of the AnchorMan LAAO device randomised controlled trial (SAFE-PROTECT trial)
AnchorMan LAAO装置随机对照试验（SAFE-PROTECT试验）的主要结果
Ben He Low dose direct oral anticoagulation vs. DAPT after LAAO
LAAO后低剂量直接口服抗凝 vs. DAPT
Xavier Freixa
Pivotal trial of targeted renal denervation to treat hypertension: SMART study
靶向去肾神经术治疗高血压的关键试验：SMART研究
Yue Wang Randomised study evaluating an intervention reducing length of stay after TAVI
一项评估减少TAVI术后住院时间的干预措施的随机研究
Eric Durand BENCHMARK: streamlined TAVI pathway with retained safety in 28 European centres
BENCHMARK研究：精简的TAVI途径在28个欧洲中心保持了安全性
Derk Frank
LBCD：聚焦基于导线和影像的生理学
Thursday 18 May 2023
Coronary microvascular function and CT coronary angiography trial
冠状动脉微血管功能与CT冠状动脉造影试验
Novalia Sidik DEFINE-FLAIR: five-year follow-up
DEFINE-FLAIR研究：5年随访
Javier Escaned FFR in chronic coronary syndrome: a report from SCAAR
慢性冠状动脉综合征的FFR：SCAAR研究报告
Sergio Buccheri FFR-guided PCI vs. CABG – Three-year follow-up of the randomised FAME 3 trial
FFR引导的PCI vs. CABG——FAME 3随机试验的3年随访
Frederik Zimmermann Prognostic value of post-PCI QFR in the randomized FLAVOUR trial
FLAVOUR随机试验中PCI后QFR的预后价值
Shengxian Tu Accuracy of instantaneous wave-free ratio derived from coronary angiography
冠状动脉造影得出的瞬时无波比率的准确性
Yoshinobu Onuma
Clinical Hotline：从（N）STEMI到慢性冠状动脉综合征（CCS）
Friday 19 May 2023
Selective Intracoronary hypothermia in anterior wall myocardial infarction
选择性冠状动脉内低温治疗前壁心肌梗死
Nico Pijls Real-time catheter-based microvascular obstruction detection in STEMI: results from the MOCA I study
STEMI中基于导管的实时微血管阻塞检测：MOCA I研究的结果
Marco Valgimigli QFR vs. FFR in STEMI: a substudy of the REDUCE MVI randomised clinical trial
STEMI的QFR vs. FFR：REDUCE MVI随机临床试验的子研究
Lin Wang Immediate culprit lesion primary PCI in patients with STEMI
STEMI患者罪犯血管紧急直接PCI
Nir Levi Extracorporeal membrane oxygenation vs. standard care in cardiogenic shock
心源性休克的体外膜肺氧合治疗 vs. 标准治疗
Manel Sabate Five-year clinical outcome of a the TIDES ACS study
TIDES ACS研究的5年临床结果
Frédéric Bouisset Murray law-based QFR on three-year outcomes of FORZA trial
FORZA试验3年结果：基于Murray定律的QFR
Cristina Aurigemma Quantitative flow ratio or angiography for the assessment of non-culprit lesions
定量血流分数或血管造影术对非罪犯病变的诊断价值
Tommaso Gori PCI or bypass surgery for multivessel coronary disease in diabetic population
糖尿病人群多支冠状动脉病变的PCI或搭桥手术
Jung-Min Ahn Non-cardiac mortality with elective revascularisation vs. medical therapy
择期血运重建与药物治疗的非心源性死亡率
Eliano Pio Navarese
《心关注》
将持续为您带来会议最新动态
敬请关注！
如发现文内有误请联系我们
来源：EuroPCR 2023
POCKETIN
EuroPCR 2023
由苏州工业园区东方华夏心血管健康研究院和医望共同发起的POCKETIN项目将依托人工智能学术跟踪系统，为全国广大心血管医师带来及时全面的报道。
项目得到了医师报、梅斯医学、365医学网、健康界、中华医学信息导报、心关注、医心、MedFocus等单位的大力支持。
▼更多精彩内容，请长按二维码▼
1. 相关学术信息由医望自主研发的人工智能学术跟踪机器人提供。
2. 相关学术信息由医望提供的医学翻译机器人完成翻译后邀请临床医师进行再次校对。
3. 如有内容上的不准确请微信联系我们（WeChat: TIANNA-AI999）
